Related Experiment Video
Updated: Jun 28, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Diabetes screening, diagnosis, and therapy in pediatric patients with type 2 diabetes
1AACE Diabetes Mellitus Clinical Practice Guidelines Task Force, Rockville, Maryland, USA.
Insights
Type 2 diabetes is rising in children and adolescents due to obesity. Early screening, diagnosis, and lifestyle interventions are crucial for managing pediatric diabetes and preventing long-term complications.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Public Health
Background:
- Type 2 diabetes mellitus incidence is increasing in pediatric and adolescent populations.
- This rise is linked to epidemics of overweight, obesity, insulin resistance, and metabolic syndrome.
- Nearly 50% of pediatric diabetes cases may be type 2, necessitating careful diagnosis.
Purpose of the Study:
- To highlight the importance of screening high-risk pediatric patients for diabetes and prediabetes.
- To emphasize the need for prompt diagnosis and accurate classification of diabetes in children.
- To underscore the benefits of early intervention and appropriate treatment in this age group.
Main Methods:
- Review of current literature on pediatric type 2 diabetes.
- Analysis of trends in pediatric diabetes incidence and prevalence.
- Discussion of diagnostic criteria and treatment strategies for pediatric diabetes.
Main Results:
- Lifestyle interventions (diet, exercise, weight loss) are the cornerstone of treatment for pediatric type 2 diabetes.
- Oral antidiabetic agents are often necessary when lifestyle changes are insufficient.
- Most pediatric patients with type 2 diabetes will eventually require insulin therapy, with insulin analogs offering improved glycemic control.
Conclusions:
- Early screening and diagnosis of type 2 diabetes in children are critical for timely and effective management.
- Lifestyle modifications are paramount, but pharmacologic interventions, including insulin, are frequently required.
- Prompt and accurate diabetes classification in pediatric patients can mitigate lifelong complication risks.
Abstract:
The dramatic rise in the incidence and prevalence of type 2 diabetes mellitus in the pediatric and adolescent populations has been associated with the ongoing epidemic of overweight, obesity, insulin resistance, and metabolic syndrome seen in these age groups. Although the majority of pediatric patients diagnosed with diabetes are still classified as having type 1 diabetes, almost 50% of patients with diabetes in the pediatric age range (under 18 years) may have type 2 diabetes. Screening of high-risk patients for diabetes and prediabetes is important. Prompt diagnosis and accurate diabetes classification facilitate appropriate and timely treatment and may reduce the risk for complications. This is especially important in children because lifestyle interventions may be successful and the lifelong risk for complications is greatest. Treatment usually begins with dietary modification, weight loss, and a structured program of physical exercise. Oral antidiabetic agents are added when lifestyle intervention alone fails to maintain glycemic control. Given the natural history of type 2 diabetes, most if not all patients will eventually require insulin therapy. In those requiring insulin, improved glycemic control and reduced frequency of hypoglycemia can be achieved with insulin analogs. It is common to add insulin therapy to existing oral therapy only when oral agents no longer provide adequate glycemic control.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction